Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 200

1.

Health consequences of visceral obesity.

Després JP.

Ann Med. 2001 Nov;33(8):534-41. Review.

PMID:
11730160
[PubMed - indexed for MEDLINE]
2.

[Risk factors associated with obesity: a metabolic perspective].

Després JP, Pascot A, Lemieux I.

Ann Endocrinol (Paris). 2000 Dec;61 Suppl 6:31-38. Review. French.

PMID:
11148334
[PubMed - indexed for MEDLINE]
3.

Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors.

Lemieux I, Alméras N, Mauriège P, Blanchet C, Dewailly E, Bergeron J, Després JP.

Can J Cardiol. 2002 Jul;18(7):725-32.

PMID:
12167959
[PubMed - indexed for MEDLINE]
4.

Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy?

Imbeault P, Lemieux S, Prud'homme D, Tremblay A, Nadeau A, Després JP, Mauriège P.

Metabolism. 1999 Mar;48(3):355-62.

PMID:
10094113
[PubMed - indexed for MEDLINE]
5.

Cardiovascular disease under the influence of excess visceral fat.

Després JP.

Crit Pathw Cardiol. 2007 Jun;6(2):51-9. Review.

PMID:
17667865
[PubMed - indexed for MEDLINE]
6.

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Nesto RW.

Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.

PMID:
16259526
[PubMed - indexed for MEDLINE]
7.

Childhood obesity, adipose tissue distribution, and the pediatric practitioner.

Slyper AH.

Pediatrics. 1998 Jul;102(1):e4. Review.

PMID:
9651456
[PubMed - indexed for MEDLINE]
8.

Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?

Lemieux I, Poirier P, Bergeron J, Alméras N, Lamarche B, Cantin B, Dagenais GR, Després JP.

Can J Cardiol. 2007 Oct;23 Suppl B:23B-31B. Review. Erratum in: Can J Cardiol. 2009 Mar;25(3):140.

PMID:
17932584
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Lipoprotein abnormalities and their consequences for patients with type 2 diabetes.

Krentz AJ.

Diabetes Obes Metab. 2003 Nov;5 Suppl 1:S19-27. Review.

PMID:
14984018
[PubMed - indexed for MEDLINE]
10.

[Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].

Slapikas R, Luksiene D, Slapikiene B, Babarskiene MR, Grybauskiene R, Linoniene L.

Medicina (Kaunas). 2005;41(11):925-31. Lithuanian.

PMID:
16333215
[PubMed - indexed for MEDLINE]
Free Article
11.

Is the gender difference in LDL size explained by the metabolic complications of visceral obesity?

Lemieux I, Pascot A, Lamarche B, Prud'homme D, Nadeau A, Bergeron J, Després JP.

Eur J Clin Invest. 2002 Dec;32(12):909-17.

PMID:
12534450
[PubMed - indexed for MEDLINE]
12.

[Body fat distribution: its characteristics and relationship to cardiovascular risk factors in obese Chinese].

Ran XW, Li XS, Tong NW, Li QF, Tang BD, Li XJ.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Sep;35(5):699-703. Chinese.

PMID:
15460424
[PubMed - indexed for MEDLINE]
13.

Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity.

Pascot A, Lemieux I, Prud'homme D, Tremblay A, Nadeau A, Couillard C, Bergeron J, Lamarche B, Després JP.

J Lipid Res. 2001 Dec;42(12):2007-14.

PMID:
11734573
[PubMed - indexed for MEDLINE]
Free Article
14.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
[PubMed - indexed for MEDLINE]
15.

Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women.

Pascot A, Lemieux S, Lemieux I, Prud'homme D, Tremblay A, Bouchard C, Nadeau A, Couillard C, Tchernof A, Bergeron J, Després JP.

Diabetes Care. 1999 Sep;22(9):1471-8.

PMID:
10480511
[PubMed - indexed for MEDLINE]
Free Article
16.

Role of fibric acid derivatives in the management of risk factors for coronary heart disease.

Després JP, Lemieux I, Robins SJ.

Drugs. 2004;64(19):2177-98. Review.

PMID:
15456334
[PubMed - indexed for MEDLINE]
17.

The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk.

Després JP.

Obes Res. 1998 Apr;6 Suppl 1:8S-17S. Review.

PMID:
9569171
[PubMed - indexed for MEDLINE]
18.

Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.

Kwiterovich PO Jr.

Am J Cardiol. 2002 Oct 17;90(8A):30i-47i. Review.

PMID:
12419479
[PubMed - indexed for MEDLINE]
19.

Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men.

Couillard C, Vohl MC, Engert JC, Lemieux I, Houde A, Almeras N, Prud'homme D, Nadeau A, Despres JP, Bergeron J.

J Lipid Res. 2003 May;44(5):986-93. Epub 2003 Feb 16.

PMID:
12588953
[PubMed - indexed for MEDLINE]
Free Article
20.

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Després JP.

Circulation. 2000 Jul 11;102(2):179-84.

PMID:
10889128
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk